A nanoagent for concurrent therapy of breast cancer bone metastasis and cancer-induced bone pain through SLC7A11 interruption and photodynamic therapy
a Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450001, China
b School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China
c Translational Medical Center of Huaihe Hospital, Henan University, Kaifeng 475004, China
d Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China
收起